Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

NCT07038356 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

536

Enrollment

OTHER

Sponsor class

Conditions

Acute Decompensated Heart Failure (ADHF)

Interventions

DRUG: Empagliflozin 10 MG Oral Tablet [Jardiance]
DRUG: Placebo

Sponsor

Christian Schulze